Peripheral Arterial Disease and Risk of Atrial Fibrillation and Stroke: the Multi-Ethnic Study of Atherosclerosis

Overview

Journal J Am Heart Assoc

Specialty Cardiology & Vascular Diseases

Date 2014 Nov 19

PMID 25404190

Citations 24

Authors

Wesley T ONeal

Jimmy T Efird

Saman Nazarian

Alvaro Alonso

Susan R Heckbert

Elsayed Z Soliman

Affiliations

Soon will be listed here.

Abstract

Background: Peripheral arterial disease (PAD) shares several risk factors with atrial fibrillation (AF), and persons with PAD have an increased risk of stroke. It is unclear if PAD is associated with an increased risk for AF and whether this potential association explains the increased risk of stroke observed in those with PAD.

Methods And Results: We examined the association between PAD, measured by ankle-brachial index (ABI), and incident AF and incident stroke, separately, in 6568 participants (mean age 62±10 years, 53% women, 62% nonwhite) from the Multi-Ethnic Study of Atherosclerosis (MESA). ABI values <1.0 or >1.4 defined PAD. AF was ascertained through review of hospital discharge records and from Medicare claims data until December 31, 2010. An independent adjudication committee ascertained stroke events. Cox regression was used to estimate hazard ratios and 95% CIs for the association between PAD and AF and stroke. Over a median follow-up of 8.5 years, 301 (4.6%) participants developed AF and 140 (2.1%) developed stroke. In a model adjusted for sociodemographics, cardiovascular risk factors, and potential confounders, PAD was associated with an increased risk of AF (hazard ratio 1.5, 95% CI 1.1 to 2.0). In a similar model, PAD was associated with incident stroke (hazard ratio 1.7, 95% CI 1.1 to 2.5), and the magnitude of risk was not different after inclusion of AF as a time-dependent covariate (hazard ratio 1.7, 95% CI 1.1 to 2.5).

Conclusions: PAD is associated with an increased risk of AF and stroke in MESA. Potentially, the relationship between PAD and stroke is not mediated by AF.

Citing Articles

Burden of cardiometabolic disease attributable to sugar sweetened beverages consumption in North Africa and the Middle East from 1990 to 2021.

Bastan M, Nejadghaderi S, Khanmohammadi S, Behnoush A, Khalaji A, Malekpour M J Diabetes Metab Disord. 2025; 24(1):66.

PMID: 39959579 PMC: 11822180. DOI: 10.1007/s40200-025-01578-9.

Unveiling the Molecular Links Between Atrial Fibrillation and Atherosclerosis: Insights into Shared Pathogenesis and Ferroptosis Diagnostic Biomarkers.

Xu B, Li H, Chen H, Teng D, Gong L, Zhong L J Inflamm Res. 2024; 17:8813-8830.

PMID: 39559400 PMC: 11570537. DOI: 10.2147/JIR.S488288.

Electronic health record-wide association study for atrial fibrillation in a British cohort.

Chung S, Schmit A, Lip G, Providencia R Front Cardiovasc Med. 2023; 10:1204892.

PMID: 37840952 PMC: 10569421. DOI: 10.3389/fcvm.2023.1204892.

Guideline-directed medical therapies for comorbidities among patients with atrial fibrillation: results from GARFIELD-AF.

Camm A, Steffel J, Virdone S, Bassand J, Fox K, Goldhaber S Eur Heart J Open. 2023; 3(3):oead051.

PMID: 37293139 PMC: 10246824. DOI: 10.1093/ehjopen/oead051.

Establishment and Verification of a Nomogram for Predicting the Probability of New-Onset Atrial Fibrillation After Dual-Chamber Pacemaker Implantation.

Yang Y, Lu J, Xiong C, Shen Z, Shen C, Tong J Tex Heart Inst J. 2023; 50(3).

PMID: 37130328 PMC: 10353287. DOI: 10.14503/THIJ-21-7796.

References

Selvin E, Erlinger T . Prevalence of and risk factors for peripheral arterial disease in the United States: results from the National Health and Nutrition Examination Survey, 1999-2000. Circulation. 2004; 110(6):738-43. DOI: 10.1161/01.CIR.0000137913.26087.F0. View

Kannel W, Wolf P, Benjamin E, Levy D . Prevalence, incidence, prognosis, and predisposing conditions for atrial fibrillation: population-based estimates. Am J Cardiol. 1998; 82(8A):2N-9N. DOI: 10.1016/s0002-9149(98)00583-9. View

Aboyans V, Ho E, Denenberg J, Ho L, Natarajan L, Criqui M . The association between elevated ankle systolic pressures and peripheral occlusive arterial disease in diabetic and nondiabetic subjects. J Vasc Surg. 2008; 48(5):1197-203. DOI: 10.1016/j.jvs.2008.06.005. View

Perez M, Wang P, Larson J, Soliman E, Limacher M, Rodriguez B . Risk factors for atrial fibrillation and their population burden in postmenopausal women: the Women's Health Initiative Observational Study. Heart. 2013; 99(16):1173-8. DOI: 10.1136/heartjnl-2013-303798. View

Gray R, Tsiatis A . A linear rank test for use when the main interest is in differences in cure rates. Biometrics. 1989; 45(3):899-904. View

Suominen V, Rantanen T, Venermo M, Saarinen J, Salenius J . Prevalence and risk factors of PAD among patients with elevated ABI. Eur J Vasc Endovasc Surg. 2008; 35(6):709-14. DOI: 10.1016/j.ejvs.2008.01.013. View

Criqui M, McClelland R, McDermott M, Allison M, Blumenthal R, Aboyans V . The ankle-brachial index and incident cardiovascular events in the MESA (Multi-Ethnic Study of Atherosclerosis). J Am Coll Cardiol. 2010; 56(18):1506-12. PMC: 2962558. DOI: 10.1016/j.jacc.2010.04.060. View

Marfella R, Sasso F, Siniscalchi M, Cirillo M, Paolisso P, Sardu C . Brief episodes of silent atrial fibrillation predict clinical vascular brain disease in type 2 diabetic patients. J Am Coll Cardiol. 2013; 62(6):525-30. DOI: 10.1016/j.jacc.2013.02.091. View

Fuster V, Moreno P, Fayad Z, Corti R, Badimon J . Atherothrombosis and high-risk plaque: part I: evolving concepts. J Am Coll Cardiol. 2005; 46(6):937-54. DOI: 10.1016/j.jacc.2005.03.074. View

10.

Shadman R, Criqui M, Bundens W, Fronek A, Denenberg J, Gamst A . Subclavian artery stenosis: prevalence, risk factors, and association with cardiovascular diseases. J Am Coll Cardiol. 2004; 44(3):618-23. DOI: 10.1016/j.jacc.2004.04.044. View

11.

Alonso A, Agarwal S, Soliman E, Ambrose M, Chamberlain A, Prineas R . Incidence of atrial fibrillation in whites and African-Americans: the Atherosclerosis Risk in Communities (ARIC) study. Am Heart J. 2009; 158(1):111-7. PMC: 2720573. DOI: 10.1016/j.ahj.2009.05.010. View

12.

Fang M, Go A, Chang Y, Borowsky L, Pomernacki N, Udaltsova N . Long-term survival after ischemic stroke in patients with atrial fibrillation. Neurology. 2014; 82(12):1033-7. PMC: 3962998. DOI: 10.1212/WNL.0000000000000248. View

13.

Devereux R, Casale P, Eisenberg R, Miller D, Kligfield P . Electrocardiographic detection of left ventricular hypertrophy using echocardiographic determination of left ventricular mass as the reference standard. Comparison of standard criteria, computer diagnosis and physician interpretation. J Am Coll Cardiol. 1984; 3(1):82-7. DOI: 10.1016/s0735-1097(84)80433-7. View

14.

Gage B, Waterman A, Shannon W, Boechler M, Rich M, Radford M . Validation of clinical classification schemes for predicting stroke: results from the National Registry of Atrial Fibrillation. JAMA. 2001; 285(22):2864-70. DOI: 10.1001/jama.285.22.2864. View

15.

Wang J, Criqui M, Denenberg J, McDermott M, Golomb B, Fronek A . Exertional leg pain in patients with and without peripheral arterial disease. Circulation. 2005; 112(22):3501-8. PMC: 4285459. DOI: 10.1161/CIRCULATIONAHA.105.548099. View

16.

Jensen P, Johnson K, Floyd J, Heckbert S, Carnahan R, Dublin S . A systematic review of validated methods for identifying atrial fibrillation using administrative data. Pharmacoepidemiol Drug Saf. 2012; 21 Suppl 1:141-7. PMC: 3674852. DOI: 10.1002/pds.2317. View

17.

Huxley R, Filion K, Konety S, Alonso A . Meta-analysis of cohort and case-control studies of type 2 diabetes mellitus and risk of atrial fibrillation. Am J Cardiol. 2011; 108(1):56-62. PMC: 3181495. DOI: 10.1016/j.amjcard.2011.03.004. View

18.

Bild D, Bluemke D, Burke G, Detrano R, Diez Roux A, Folsom A . Multi-Ethnic Study of Atherosclerosis: objectives and design. Am J Epidemiol. 2002; 156(9):871-81. DOI: 10.1093/aje/kwf113. View

19.

Banerjee A, Fowkes F, Rothwell P . Associations between peripheral artery disease and ischemic stroke: implications for primary and secondary prevention. Stroke. 2010; 41(9):2102-7. DOI: 10.1161/STROKEAHA.110.582627. View

20.

Criqui M, Ninomiya J, Wingard D, Ji M, Fronek A . Progression of peripheral arterial disease predicts cardiovascular disease morbidity and mortality. J Am Coll Cardiol. 2008; 52(21):1736-42. PMC: 2871035. DOI: 10.1016/j.jacc.2008.07.060. View